Vihko P - Search Results

1

Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers.

Jernvall P, Mäkinen MJ, Karttunen TJ, Mäkelä J, Vihko P. Jernvall P, et al. Among authors: vihko p. Br J Cancer. 1999 Feb;79(5-6):903-8. doi: 10.1038/sj.bjc.6690144. Br J Cancer. 1999. PMID: 10070888 Free PMC article.

2

Conserved region mutations of the p53 gene are concentrated in distal colorectal cancers.

Jernvall P, Mäkinen M, Karttunen T, Mäkelä J, Vihko P. Jernvall P, et al. Among authors: vihko p. Int J Cancer. 1997 Feb 20;74(1):97-101. doi: 10.1002/(sici)1097-0215(19970220)74:1<97::aid-ijc17>3.0.co;2-f. Int J Cancer. 1997. PMID: 9036877

3

Morphological and genetic abnormalities in prediction of recurrence in radically operated colorectal cancer.

Jernvall P, Mäkinen MJ, Karttunen TJ, Mäkelä J, Vihko P. Jernvall P, et al. Among authors: vihko p. Anticancer Res. 1999 Mar-Apr;19(2B):1357-62. Anticancer Res. 1999. PMID: 10365106

4

Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers.

Jernvall P, Mäkinen MJ, Karttunen TJ, Mäkelä J, Vihko P. Jernvall P, et al. Among authors: vihko p. Eur J Cancer. 1999 Feb;35(2):197-201. doi: 10.1016/s0959-8049(98)00306-2. Eur J Cancer. 1999. PMID: 10448259

5

Classification of advanced colorectal carcinomas by tumor edge morphology: evidence for different pathogenesis and significance of polypoid and nonpolypoid tumors.

George SM, Mäkinen MJ, Jernvall P, Mäkelä J, Vihko P, Karttunen TJ. George SM, et al. Among authors: vihko p. Cancer. 2000 Nov 1;89(9):1901-9. doi: 10.1002/1097-0142(20001101)89:9<1901::aid-cncr5>3.3.co;2-r. Cancer. 2000. PMID: 11064346

6

Colorectal carcinoma associated with serrated adenoma--prevalence, histological features, and prognosis.

Mäkinen MJ, George SM, Jernvall P, Mäkelä J, Vihko P, Karttunen TJ. Mäkinen MJ, et al. Among authors: vihko p. J Pathol. 2001 Mar;193(3):286-94. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH800>3.0.CO;2-2. J Pathol. 2001. PMID: 11241406

7

17Beta-hydroxysteroid dehydrogenase type 2: independent prognostic significance and evidence of estrogen protection in female patients with colon cancer.

Oduwole OO, Mäkinen MJ, Isomaa VV, Pulkka A, Jernvall P, Karttunen TJ, Vihko PT. Oduwole OO, et al. Among authors: vihko pt. J Steroid Biochem Mol Biol. 2003 Nov;87(2-3):133-40. doi: 10.1016/j.jsbmb.2003.08.008. J Steroid Biochem Mol Biol. 2003. PMID: 14672733

8

Three independently deleted regions at chromosome arm 16q in human prostate cancer: allelic loss at 16q24.1-q24.2 is associated with aggressive behaviour of the disease, recurrent growth, poor differentiation of the tumour and poor prognosis for the patient.

Elo JP, Härkönen P, Kyllönen AP, Lukkarinen O, Vihko P. Elo JP, et al. Among authors: vihko p. Br J Cancer. 1999 Jan;79(1):156-60. doi: 10.1038/sj.bjc.6690025. Br J Cancer. 1999. PMID: 10408707 Free PMC article.

9

Sex steroid metabolism in human gastric mucosa: 17 beta-hydroxysteroid dehydrogenase type 2 in normal, inflamed and neoplastic gastric tissues.

Oduwole OO, Mäkinen JM, Isomaa VV, Karttunen TJ, Vihko PT. Oduwole OO, et al. Anticancer Res. 2003 Sep-Oct;23(5A):3889-97. Anticancer Res. 2003. PMID: 14666693

10

Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer.

Elo JP, Härkönen P, Kyllönen AP, Lukkarinen O, Poutanen M, Vihko R, Vihko P. Elo JP, et al. Among authors: vihko r, vihko p. Cancer Res. 1997 Aug 15;57(16):3356-9. Cancer Res. 1997. PMID: 9269995

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters